Shree Ganesh Remedies Reports Decline in Sales and Profit Amid Rising Non-Operating Income in May 2025
Shree Ganesh Remedies has announced its financial results for the quarter ending March 2025, revealing a decline in net sales to Rs 24.43 crore, the lowest in five quarters. Profit before tax was reported at Rs 6.48 crore, while profit after tax reached Rs 6.59 crore, both showing year-on-year reductions. The company noted its highest non-operating income in five quarters at Rs 2.29 crore.
Shree Ganesh Remedies, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 19, 2025, indicate notable shifts in the company's financial metrics.The company experienced a decline in net sales, which totaled Rs 24.43 crore, reflecting a significant year-on-year change. This figure marks the lowest sales recorded in the past five quarters, suggesting a challenging environment for revenue generation. Additionally, the profit before tax, excluding other income, was reported at Rs 6.48 crore, also showing a considerable year-on-year reduction. Similarly, profit after tax stood at Rs 6.59 crore, indicating a downward trend compared to the previous year.
Interestingly, Shree Ganesh Remedies reported its highest non-operating income in the last five quarters at Rs 2.29 crore. However, this increase raises questions about the sustainability of income derived from non-business activities.
In light of these developments, the stock has undergone an adjustment in its evaluation, reflecting the current financial landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
